Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 21Unknown 9Terminated 4Recruiting 4Not yet recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 40Lymphoid 32Other hematologic neoplasm 16CNS 12Genitourinary 8Other solid neoplasm 7Endocrine 5Gynecologic 4Plasma cell 3Sarcoma 2Myeloid 2NET 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Ovarian Neoplasms 3Uterine Cervical Neoplasms 1Ovarian Germ Cell Cancer 1Carcinoma 1

Interventions

Paclitaxel 81Carboplatin 67pembrolizumab 62Bevacizumab 58Cisplatin 49Specimen Handling 29Drug Therapy 26Blood Specimen Collection 23olaparib 20Cyclophosphamide 18Taxes 17Magnetic Resonance Spectroscopy 16Letrozole 16Gemcitabine 16Biopsy 16liposomal doxorubicin 15niraparib 14Brachytherapy 14fludarabine 13Radiotherapy 13abemaciclib 12Injections 12Topotecan 11Nivolumab 11Doxorubicin 11lenvatinib 10Fulvestrant 10Fluorouracil 10Surveys and Questionnaires 9Standard of Care 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Etoposide × Gynecologic × Clear all
NCT05910177 2024-03-06

Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin

Fujian Cancer Hospital

Phase 2 Recruiting
30 enrolled
Gynecologic

Carcinoma, Uterine Cervical Neoplasms

NCT02429687 2023-04-25

MOGCT-01

Shandong University

Phase 3 Recruiting
129 enrolled
Gynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms

NCT02429700 2023-04-25

SCST-01

Shandong University

Phase 3 Recruiting
132 enrolled
Gynecologic

Ovarian Neoplasms

NCT04520074 2022-07-27

Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)

Fudan University

Phase 3 Recruiting
590 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡